Philip Pizzo Net Worth & Insider Trades

Philip Pizzo - Director, Global Blood Therapeutics, Inc

As of October 6, 2022

What is Philip Pizzo's Net Worth?

The current estimated net worth of Global Blood Therapeutics, Inc's Director, Philip Pizzo, is estimated to be about $2.5M . Philip Pizzo owns about 9,112 units of Global Blood Therapeutics, Inc common stock. In the last 7 years at Global Blood Therapeutics, Inc, Philip Pizzo has sold an estimated value of $2.37M worth.

What is Philip Pizzo's Past Insider Trading?

Philip Pizzo's largest purchase order was 30,000 units , worth over $709.5K on December 13, 2019. Philip Pizzo's largest sale order was 30,000 units , worth over $2.3M on December 13, 2019. In total, Philip Pizzo has made about 11 transactions over 7 years of their time at Global Blood Therapeutics, Inc. Philip Pizzo usually trades in June, with the busiest year in 2022. The most recent transaction was a sale order of 1,260 units , worth over $34.34K on June 22, 2022.

Philip Pizzo

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Philip Pizzo's' Mailing Address?

  • Mailing address is One Commerce Street Suite 2550 Memphis TN 38103 TN

Global Blood Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ted Love, M.D. 2020 $661,250 - $11,778,840 $4,693,666 $467,000 $5,000 $17,605,756
Ted Love, M.D. 2019 $596,876 - $4,359,600 $4,595,717 $540,000 $5,000 $10,097,193
Ted Love, M.D. 2018 $568,750 - $4,648,800 $4,623,690 $414,000 $5,000 $10,260,240
David Johnson 2020 $463,750 - $4,037,361 $1,582,504 $234,000 $5,000 $6,322,615
David Johnson 2019 $453,125 - $1,211,000 $1,267,784 $250,000 $5,000 $3,186,909
David Johnson 2018 $355,000 $75,000 $1,897,750 $1,898,534 $169,000 $5,000 $4,394,284
Jeffrey Farrow 2020 $457,813 - $3,708,261 $1,582,504 $231,500 $5,000 $5,985,078
Jeffrey Farrow 2019 $440,625 - $1,211,000 $1,267,784 $244,000 $5,000 $3,168,409
Jeffrey Farrow 2018 $425,938 - $1,370,800 $1,326,469 $201,000 $5,000 $3,329,207
Jung Choi 2020 $433,125 - $3,708,261 $1,582,504 $219,000 $5,000 $5,947,890
Jung Choi 2019 $416,875 - $1,211,000 $1,267,784 $231,000 $5,000 $3,131,659
Jung Choi 2018 $392,063 - $1,370,800 $1,326,469 $185,000 $5,000 $3,279,332
Tricia Suvari 2020 $422,499 - $3,708,261 $1,582,504 $214,000 $5,000 $5,932,264
Tricia Suvari 2019 $403,125 - $1,211,000 $1,267,784 $223,000 $5,000 $3,109,909
Tricia Suvari 2018 $386,875 - $1,549,600 $1,515,964 $183,000 $5,000 $3,640,439
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm

What are Global Blood Therapeutics, Inc's Past Insider Trades?

Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks,  Ted Love, President and CEO,  and Borga Tricia Suvari, Chief Legal Officer .

Global Blood Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1